- Division Chief, Solid Tumor Oncology, UH Cleveland Medical Center
- George and Edith Richman Distinguished Scientist Chair, UH Cleveland Medical Center
- Director, GU Oncology Research Program, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Jorge A. Garcia, MD, FACP, is a Professor of Medicine and Urology at Case Western Reserve University in Cleveland, Ohio. He is the George and Edith Richman Distinguished Scientist Chair and the current chair of the Solid Tumor Oncology Division at University Hospitals Seidman Cancer Center/Case Comprehensive Cancer Center. Dr. Garcia’s work focuses on genitourinary malignancies. He is the current director of the GU Medical Oncology clinical and research programs at University Hospitals Seidman Cancer Center.
Dr. Garcia earned his medical degree at the Colombian School of Medicine in Bogota, Colombia (South America). After completing a Cancer Biology Fellowship at Harvard Medical School, Dr. Garcia completed his training in Internal Medicine at the Albert Einstein College of Medicine in New York. Subsequently, Dr. Garcia completed his fellowship in hematology and medical oncology and urologic oncology at the University of California San Francisco.
Certified in Medical Oncology and Internal Medicine by the American Board of Internal Medicine, Dr. Garcia’s primary research interests have been in prostate, kidney and bladder cancer, with special focus on developmental therapeutics, immune oncology and targeted therapy. Dr. Garcia has authored more than 250 manuscripts and book chapters and his research has been published in peer-reviewed journals including New England Journal of Medicine, Clinical Cancer Research, Journal of Clinical Oncology, Lancet, JAMA, Cancer, Journal of the National Cancer Institute, Journal of Urology and BJU International, among others. He has also served on numerous editorial boards as editor and reviewer.
Dr. Garcia came to UH Seidman Cancer Center after spending 16 years at the Cleveland Clinic, where he served as the Kerscher Family Chair for Prostate Cancer Research and a staff physician in the medical oncology and urology departments. While at the Cleveland Clinic, Dr. Garcia also served as the chair of the Case Comprehensive Cancer Center PRMC and more recently as the director of the cancer center’s clinical research office.
Dr. Garcia is a member of several professional societies, including the American College of Physicians, Association of Cancer Research, American Society of Clinical Oncology and the American Medical Association. Dr. Garcia is a Fellow of the American College of Physicians and has served in the past as a relevance reviewer for the American Board of Internal Medicine. Dr. Garcia has been listed among the best doctors in Cleveland and the U.S. every year since 2009.
- Clinical Research
- Experimental Therapeutics
- GU Medical Oncology
Patient Experience Reviews
4.9 out of 5
Patient Comments (6)
Reviewed On 8/1/2022
Great Dr. He in very thorough.
Reviewed On 7/1/2022
I love all my providers cuz they'll sit back and explain stuff to me if I don't understand it then make it clear they very good in what they do and I'll applause them for their job they do and may God bless them the whole entire hospital I like
Reviewed On 6/1/2022
Dr. Garcia has been my doctor for a long time, he has helped me for 20 plus years fighting prostate cancer, I have total confidence in him!
Reviewed On 4/1/2022
I have seen Dr. Garcia for 13 years. He is without a doubt the best physician I have ever had. He listens to what I have to say and always explains treatment well and in depth. He is caring and empathetic. He is also up to date on the latest treatments and care. He always follows up with me and clearly cares about his patients. I respect him immensely.
Reviewed On 3/1/2022
Dr Garcia is the best. I am very grateful to work with him.
Reviewed On 3/1/2022
Dr Garcia was excellent and explained everything with the options and recommended the next procedure for my *** cancer. He was kind and very knowledgeable and it was a pleasure to talk with him
Certifications & Memberships
- Medical Oncology - American Board of Internal Medicine
Fellowship | Urologic Oncology
Urologic Oncology - UCSF Medical Center (2003 - 2004)
Fellowship | Hematology/Oncology
Hematology/Oncology - UCSF Medical Center (2001 - 2003)
Residency | Internal Medicine
Internal Medicine - Albert Einstein College Of Medicine Of Yeshiva University (1998 - 2001)
Research Fellowship | Cancer Biology
Cancer Biology - Harvard Medical School (1995 - 1998)
Escuela Colombiana De Medicina (1994)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jorge Garcia did not disclose any Outside Relationships with Industry.